Picodya shortlisted for the prestigious
Picodya Technologies Ltd. has been shortlisted as a finalist in the prestigious Genesis Prize competition. This unique competition, initiated by 2020 Genesis Prize Laureate Natan Sharansky in cooperation with the Genesis Prize Foundation and Start-Up Nation Central, recognizes leading Israeli companies working to combat coronavirus and the damage of future pandemics. Picodya was selected by a distinguished judging panel in the “Diagnostics & Decision Support” category for its IVD platform suitable for point-of-care deployment, which will be invaluable during this and other healthcare crises.
If you’re interested in Picodya and learning more about our game-changing B-Matrix™ technology, simply enter your details below. We’ll be happy to share further details and discuss our vision for better, cheaper, more accessible diagnostics worldwide.